BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20418191)

  • 1. Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma.
    Piscaglia F; Leoni S; Cabibbo G; Borghi A; Imbriaco G; Golfieri R; Bolondi L
    Dig Liver Dis; 2010 Oct; 42(10):729-34. PubMed ID: 20418191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.
    Sangiovanni A; Manini MA; Iavarone M; Romeo R; Forzenigo LV; Fraquelli M; Massironi S; Della Corte C; Ronchi G; Rumi MG; Biondetti P; Colombo M
    Gut; 2010 May; 59(5):638-44. PubMed ID: 19951909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance for hepatocellular carcinoma: does it work?
    Mallat DB; El-Serag HB
    Am J Gastroenterol; 2002 Oct; 97(10):2676-7. PubMed ID: 12385462
    [No Abstract]   [Full Text] [Related]  

  • 4. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.
    Shah TU; Semelka RC; Pamuklar E; Firat Z; Gerber RD; Shrestha R; Russo MW
    Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging diagnosis of hepatocellular carcinoma with differentiation from other pathology.
    Kim TK; Jang HJ; Wilson SR
    Clin Liver Dis; 2005 May; 9(2):253-79. PubMed ID: 15831272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver.
    Khan AS; Hussain HK; Johnson TD; Weadock WJ; Pelletier SJ; Marrero JA
    J Magn Reson Imaging; 2010 Aug; 32(2):360-6. PubMed ID: 20677263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for hepatocellular carcinoma in cirrhotic patients.
    Miller JC; Hahn PF; Chung RT; Thrall JH; Lee SI
    J Am Coll Radiol; 2008 Sep; 5(9):1012-4. PubMed ID: 18755444
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for hepatocellular carcinoma: Is it cost-effective?
    Wolf DC
    Liver Transpl; 2003 Jul; 9(7):682-3. PubMed ID: 12827552
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of biphasic spiral CT, conventional and iron oxide enhanced MRI on therapy and therapy costs in patients with focal liver lesions].
    Helmberger T; Gregor M; Holzknecht N; Rau H; Scheidler J; Reiser M
    Rofo; 2000 Mar; 172(3):251-9. PubMed ID: 10778456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Integrated diagnosis of small hepatocellular carcinoma with imaging diagnosis].
    Sekoguchi B; Horiguchi Y; Imai H; Suzuki T; Miyoshi A; Itoh H; Kubo H; Itoh M
    Rinsho Byori; 1994 Oct; 42(10):1036-42. PubMed ID: 7996712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of intrainstitutional information exchange in the diagnostic and therapeutic management of hepatocellular carcinoma.
    Bartolozzi C; Caramella D; Lencioni R; Bassi AM; Moretti M; Armillotta N; del Sarto M
    Acad Radiol; 1996 Apr; 3 Suppl 1():S77-9. PubMed ID: 8796522
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost analysis of tumor downsizing for hepatocellular carcinoma liver transplant candidates.
    De Simone P; Vignali C; Petruccelli S; Carrai P; Coletti L; Montin U; Catalano G; Urbani L; Filipponi F
    Transplant Proc; 2006 Dec; 38(10):3561-3. PubMed ID: 17175331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion-and diffusion-weighted imaging of hepatocellular carcinoma.
    Vandecaveye V; De Keyzer F; Dymarkowski S
    JBR-BTR; 2007; 90(6):492-6. PubMed ID: 18376763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Imaging procedures in diagnosis of large solitary highly differentiated hepatocellular cancer--is it useful?].
    Kamilli I; Rauh G; Hahn D; Izbicki J; Zoller WG
    Bildgebung; 1993 Mar; 60(1):31-4. PubMed ID: 8387362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic imaging and therapy of hepatocellular carcinoma].
    Allgaier HP; Deibert P; Blum HE
    Dtsch Med Wochenschr; 1997 Dec; 122(50):1573-5. PubMed ID: 9445781
    [No Abstract]   [Full Text] [Related]  

  • 18. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
    Amarapurkar D; Han KH; Chan HL; Ueno Y;
    J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Imaging diagnosis of hepatocellular carcinoma].
    Yan FH
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):297-9. PubMed ID: 15854501
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiologic diagnosis of hepatocellular carcinoma.
    Ishiguchi T; Shimamoto K; Fukatsu H; Yamakawa K; Ishigaki T
    Semin Surg Oncol; 1996; 12(3):164-9. PubMed ID: 8727605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.